Guardant Health is undervalued, making it a good time to accumulate more holdings. The company's positive future outlook isn't fully reflected in the current share price. Consider financial health before investing.
The recent share price drop may indicate unresolved challenges, despite the company's revenue growth. Investors are advised to ensure they are buying a high-quality business, even when the share price is low.
Guardant Health's high P/S ratio is due to strong revenue performance and promising future growth rates, bolstering shareholder confidence. Given the optimism, a significant stock price drop is unlikely soon.
Substantial insider acquisitions point to optimism for the company's prospects. However, the recent sale by the CIO may suggest some insiders think shares are overvalued. Still, high insider ownership implies alignment of management's interests with shareholders.
Wolfe Research Downgrades$スノーフレーク(SNOW.US)$to Peer Perform From Outperform Snowflake (SNOW) has an average rating of outperform and price targets ranging from $105 to $500, according to analysts polled by Capital IQ. Guggenheim Downgrades$モンゴDB(MDB.US)$to Sell From Neutral, Adjusts Price Target to $210 From $205 MongoDB (MDB) has an average rating of outperform and price targets ranging from $180 to $365, according to analysts po...
Gapping up $アドビ(ADBE.US)$+4.6%(The software company reported better-than-expected quarterly earnings and revenue that was in line with analyst forecasts. Adobe also issued upbeat current quarter guidance.) $ダーデン・レストランツ(DRI.US)$+1% (The parent of Olive Garden and other restaurant chains reported for its latest quarter, and exceeded analyst forecasts for same-restaurant sales. Darden also raised the lower end of its 2023 ea...
RIPPER :
Someone probably knows some thing… I noticed this happens a lot beef for a company announces some very good news… Sometimes that news does not come for a few days, a week or even two. Almost as if they know too short sell the price so they can accumulate at a substantially lower price before the news comes out. Of course I’m just speculating and it certainly is not always the case however in a few a few recent scenarios that’s the vibes I felt
ガーダント・ヘルスに関するコメント
コラムUS Top Rating Updates on 5/26: SNOW, MDB, UNH, GH and More
Snowflake (SNOW) has an average rating of outperform and price targets ranging from $105 to $500, according to analysts polled by Capital IQ.
Guggenheim Downgrades $モンゴDB(MDB.US)$ to Sell From Neutral, Adjusts Price Target to $210 From $205
MongoDB (MDB) has an average rating of outperform and price targets ranging from $180 to $365, according to analysts po...
コラムToday's Pre-Market Stock Movers: ADBE, META, ACN, MAXR and More
$アドビ(ADBE.US)$ +4.6%(The software company reported better-than-expected quarterly earnings and revenue that was in line with analyst forecasts. Adobe also issued upbeat current quarter guidance.)
$ダーデン・レストランツ(DRI.US)$ +1% (The parent of Olive Garden and other restaurant chains reported for its latest quarter, and exceeded analyst forecasts for same-restaurant sales. Darden also raised the lower end of its 2023 ea...
What with this ? Too oversold
コラムToday's pre-market stock movers: PLTR, BBBY, BNTX, GOLD and more
In reaction to earnings/guidance:
• $Karuna Therapeutics(KRTX.US)$ +42.6% (also reports topline results from its Phase3 EMERGENT-2 trial evaluating the efficacy, safety, and tolerability of its lead investigational therapy, KarXT), $マンデー・ドット・コム(MNDY.US)$ +15.1%,$W&Tオフショア(WTI.US)$ +6.7%,$HFシンクレア(DINO.US)$ +5.3%,$ヴィアトリス(VTRS.US)$ +4.3%,$コスモス・エナジー(KOS.US)$ + 3.2%,$Holly Energy(HEP.US)$ +3.2%,$バリック・ゴールド(GOLD.US)$ +2.9%,...
コラムTop upgrades and downgrades on 6/3
• $シエナ(CIEN.US)$: B.Riley Upgrades to Buy from Neutral - PT $67 (from $65)
• $エコラボ(ECL.US)$: Credit Suisse Upgrades to Outperform from Neutral - PT $195 (from $180)
• $Hersha Hospitality Trust(HT.US)$: Jefferies Upgrades to Buy from Neutral - PT $13 (from $11)
• $マーチン・マリエッタ・マテリアルズ(MLM.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $410 (from $420)
• $ポートランド・ジェネラル・エレクトリック(POR.US)$: Goldman Sachs Upgrades to Buy from Neutral - P...
まだコメントはありません